Investing Profile

Paul Stoffels

Photo of Paul Stoffels, Vice President at Johnson & Johnson Innovation

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Johnson & Johnson Network
17 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
cb
1
CompanyStageDateRound SizeTotal Raised
Frontier Medicines
Series CFeb 2024$80M
$260M
Co-investors: Derek DiRocco (RA Capital)
Chief Scientific Officer Johnson & Johnson2012 - Present
Worldwide Chairman, Phamaceuticals Johnson & Johnson2011 - 2016
Global Head, Pharmaceutical Reseach and Development Johnson & Johnson2009 - 2011
University of Antwerp
Infectious Diseases and Tropical Medicine at the Institute of Tropical Medicine
University of Diepenbeek